Elite Trades From Anywhere

$100 Off Your First Year

00
Days
00
Hours
00
Mins
00
Sec
Claim Now
Last Close
173.06
Jul 02 • 04:00PM ET Dollar change-1.99 Percentage change(-1.14%)
Index
-
Market Cap
13.25B
Enterprise Value
16.03B
Income
173.28M
Sales
8.27B
Book/sh
121.41
Cash/sh
9.99
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
40100
IPO
May 15, 1998
P/E
79.71
Forward P/E
14.50
PEG
6.25
P/S
1.60
P/B
1.43
P/C
17.32
P/FCF
16.86
EV/EBITDA
11.95
EV/Sales
1.94
Quick Ratio
1.14
Current Ratio
1.14
Debt/Eq
0.38
LT Debt/Eq
0.32
Option/Short
Yes / Yes
EPS (ttm)
2.17
EPS next Y
11.93
EPS next Q
2.55
EPS this Y
-15.12%
EPS next Y
12.19%
EPS next 5Y
2.32%
EPS past 3/5Y
-22.33% -14.31%
Sales past 3/5Y
2.15% 24.15%
EPS Y/Y TTM
-76.28%
Sales Y/Y TTM
0.77%
EPS Q/Q
-31.77%
Sales Q/Q
0.93%
Insider Own
0.93%
Insider Trans
0.00%
Inst Own
105.48%
Inst Trans
3.88%
ROA
1.05%
ROE
1.85%
ROIC
1.41%
Gross Margin
20.68%
Oper. Margin
11.22%
Profit Margin
2.10%
SMA20
11.84%
SMA50
29.71%
SMA200
15.97%
Trades
Shs Outstand
76.60M
Shs Float
75.85M
52W High
211.00 -17.98%
52W Low
66.57 159.97%
Volatility
5.41% 5.21%
ATR (14)
8.24
RSI (14)
72.75
Beta
1.20
Rel Volume
0.78
Avg Volume
1.20M
Volume
938,188
Perf Week
7.52%
Perf Month
25.83%
Perf Quarter
55.32%
Perf Half Y
-5.43%
Perf YTD
-5.03%
Perf Year
14.75%
Perf 3Y
-30.83%
Perf 5Y
-19.54%
Perf 10Y
144.99%
Prev Close
175.05
Price
173.06
Change
-1.14%
Date Action Analyst Rating Change Price Target Change
Jun-30-26Upgrade Truist Hold → Buy $207
Jun-25-26Upgrade RBC Capital Mkts Sector Perform → Outperform $185
May-18-26Resumed RBC Capital Mkts Sector Perform $123
Mar-26-26Upgrade BMO Capital Markets Market Perform → Outperform $130
Feb-23-26Upgrade Jefferies Hold → Buy $135
Feb-18-26Upgrade TD Cowen Hold → Buy $120
Feb-17-26Downgrade Rothschild & Co Redburn Buy → Neutral $100
Feb-12-26Downgrade Leerink Partners Outperform → Market Perform $105
Feb-12-26Downgrade BofA Securities Neutral → Underperform $75
Jan-08-26Downgrade Truist Buy → Hold $222
Jun-24-26 03:00PM
Jun-23-26 04:15PM
Jun-22-26 07:00AM
Jun-17-26 04:15PM
May-29-26 08:30AM
07:02PM Loading…
May-28-26 07:02PM
May-18-26 09:55AM
May-13-26 08:00AM
Mar-26-26 09:45AM
Mar-24-26 08:00AM
Mar-11-26 06:00AM
Mar-10-26 09:11AM
Mar-09-26 12:17AM
Mar-05-26 09:56AM
Mar-02-26 12:55AM
04:23AM Loading…
Mar-01-26 04:23AM
Feb-26-26 06:45PM
Feb-24-26 02:46PM
Feb-23-26 09:08PM
Feb-18-26 10:10AM
Feb-17-26 09:43AM
Feb-15-26 08:32AM
Feb-14-26 08:17AM
Feb-13-26 11:25PM
Feb-12-26 04:16PM
02:19PM
11:10AM
10:07AM
09:44AM
07:38AM
10:00AM Loading…
Feb-11-26 10:00AM
Feb-05-26 07:23PM
Jan-27-26 07:15AM
Jan-22-26 12:06AM
Jan-05-26 07:27AM
Dec-17-25 08:53AM
Dec-10-25 10:31AM
Dec-09-25 07:46AM
07:15AM
Dec-02-25 07:15AM
Nov-27-25 11:30AM
Nov-26-25 06:27PM
Nov-25-25 07:46AM
Nov-21-25 11:30AM
Nov-13-25 09:11AM
Nov-12-25 06:45AM
Nov-06-25 07:28PM
Oct-24-25 06:41PM
Oct-23-25 11:15AM
Oct-22-25 05:45PM
04:25PM
Oct-20-25 10:00AM
Oct-15-25 10:00AM
Oct-01-25 06:48PM
Sep-26-25 08:52AM
Sep-14-25 01:17AM
Sep-09-25 12:11PM
Sep-04-25 08:00AM
Sep-02-25 06:00AM
Sep-01-25 12:20PM
Aug-18-25 06:45PM
Aug-12-25 11:41PM
08:54AM
Aug-11-25 07:50AM
Aug-06-25 06:42PM
Jul-25-25 09:45PM
Jul-24-25 06:37PM
Jul-23-25 05:50PM
04:20PM
04:15PM
Jul-17-25 10:00AM
Jul-16-25 10:00AM
07:15AM
Jul-15-25 09:32AM
Jul-07-25 07:15AM
07:06AM
Jul-03-25 10:13AM
Jun-27-25 09:15AM
Jun-23-25 06:30AM
Jun-02-25 10:23AM
04:12AM
May-30-25 11:31AM
May-27-25 08:30AM
May-19-25 04:15PM
May-14-25 07:52AM
May-09-25 03:13AM
May-07-25 12:55PM
07:27AM
May-02-25 09:00PM
03:01AM
02:42AM
May-01-25 06:43PM
09:16AM
Apr-30-25 06:15PM
05:23PM
04:15PM
Apr-29-25 09:12AM
Apr-27-25 04:19PM
Apr-24-25 10:01AM
Apr-23-25 10:01AM
ICON plc engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The firm specializes in the development, management, and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S., and Rest of World. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
CEO & DirectorMr. Barry Balfe
Founder & Independent Non-Executive DirectorDr. John Climax Ph.D.
Chief Financial OfficerMr. Nigel Clerkin A.C.A.
Chief Commercial OfficerMr. Steve Empoliti
Chief Accounting OfficerLyons Emer
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARRY EDWARD BALFEOfficerMar 09 '26Proposed Sale105.132,862300,875Mar 09 05:14 PM
BARRY EDWARD BALFEOfficerMar 04 '26Proposed Sale109.2556661,837Mar 04 04:07 PM
NIGEL CLERKINOfficerNov 03 '25Proposed Sale169.241,473249,289Nov 03 04:23 PM
STEPHEN CUTLEROfficerOct 02 '25Proposed Sale190.1918,9013,594,781Oct 02 04:03 PM
BARRY EDWARD BALFEOfficerAug 08 '25Proposed Sale157.4638159,993Aug 08 04:33 PM
THOMAS NOEL O'LEARYOfficerAug 08 '25Proposed Sale157.461,136178,877Aug 08 04:27 PM